HRP20250022T1 - Liječenje kolestatskog pruritusa sa seladelparom - Google Patents

Liječenje kolestatskog pruritusa sa seladelparom Download PDF

Info

Publication number
HRP20250022T1
HRP20250022T1 HRP20250022TT HRP20250022T HRP20250022T1 HR P20250022 T1 HRP20250022 T1 HR P20250022T1 HR P20250022T T HRP20250022T T HR P20250022TT HR P20250022 T HRP20250022 T HR P20250022T HR P20250022 T1 HRP20250022 T1 HR P20250022T1
Authority
HR
Croatia
Prior art keywords
compound
use according
day
seladelpar
amount
Prior art date
Application number
HRP20250022TT
Other languages
English (en)
Croatian (hr)
Inventor
Pol Boudes
Charles A. Mcwherter
Alexandra S. Steinberg
Original Assignee
Cymabay Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cymabay Therapeutics, Inc. filed Critical Cymabay Therapeutics, Inc.
Publication of HRP20250022T1 publication Critical patent/HRP20250022T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Ladders (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20250022TT 2017-09-26 2018-09-24 Liječenje kolestatskog pruritusa sa seladelparom HRP20250022T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762563395P 2017-09-26 2017-09-26
EP21201888.1A EP3973959B8 (en) 2017-09-26 2018-09-24 Treatment of cholestatic pruritus with seladelpar

Publications (1)

Publication Number Publication Date
HRP20250022T1 true HRP20250022T1 (hr) 2025-03-14

Family

ID=64564950

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20212010TT HRP20212010T1 (hr) 2017-09-26 2018-09-24 Liječenje kolestatskog pruritusa sa seladelparom
HRP20250022TT HRP20250022T1 (hr) 2017-09-26 2018-09-24 Liječenje kolestatskog pruritusa sa seladelparom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HRP20212010TT HRP20212010T1 (hr) 2017-09-26 2018-09-24 Liječenje kolestatskog pruritusa sa seladelparom

Country Status (26)

Country Link
US (2) US20190105291A1 (enExample)
EP (3) EP3973959B8 (enExample)
JP (1) JP7023371B2 (enExample)
KR (1) KR102376794B1 (enExample)
CN (1) CN111132675B (enExample)
AU (2) AU2018342323B2 (enExample)
BR (1) BR112020005074A2 (enExample)
CA (1) CA3076614C (enExample)
CY (1) CY1124894T1 (enExample)
DK (1) DK3973959T3 (enExample)
ES (2) ES2902349T3 (enExample)
FI (1) FI3973959T3 (enExample)
HR (2) HRP20212010T1 (enExample)
HU (2) HUE070033T2 (enExample)
IL (2) IL273569B (enExample)
LT (2) LT3973959T (enExample)
MX (1) MX392537B (enExample)
PL (2) PL3687523T3 (enExample)
PT (2) PT3687523T (enExample)
RS (1) RS62790B1 (enExample)
SG (1) SG11202002253SA (enExample)
SI (2) SI3973959T1 (enExample)
SM (1) SMT202200171T1 (enExample)
UA (1) UA125600C2 (enExample)
WO (1) WO2019067373A1 (enExample)
ZA (1) ZA202001646B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10272058B2 (en) 2014-03-20 2019-04-30 Cymabay Therapeutics, Inc. Treatment of intrahepatic cholestatic diseases
HUE041733T2 (hu) 2014-03-20 2019-05-28 Cymabay Therapeutics Inc Intrahepatikus kolesztázisos betegségek kezelése
US12053445B2 (en) 2016-03-31 2024-08-06 Genfit Methods of treatment of cholestatic diseases
US10512622B2 (en) 2017-07-14 2019-12-24 Cymabay Therapeutics, Inc. Treatment of intrahepatic cholestatic diseases
CN114980876A (zh) * 2020-02-10 2022-08-30 基恩菲特公司 用艾拉菲诺治疗原发性胆汁性胆管炎
CN116490191A (zh) * 2020-10-20 2023-07-25 葛兰素史克知识产权第二有限公司 治疗胆汁淤积性瘙痒的方法
SI4225291T1 (sl) 2021-02-01 2024-07-31 CymaBay Therapeutics, Inc., Zdravljenje holangiopatij s seladelparjem
US20240252499A1 (en) 2023-01-29 2024-08-01 Cymabay Therapeutics, Inc. Treatment of uremic pruritus
CN120529903A (zh) 2023-01-29 2025-08-22 西玛贝医药公司 慢性瘙痒性皮肤病的治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2539446C (en) 2003-09-19 2013-12-03 Janssen Pharmaceutica, N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JO3006B1 (ar) 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
HUE041733T2 (hu) 2014-03-20 2019-05-28 Cymabay Therapeutics Inc Intrahepatikus kolesztázisos betegségek kezelése
US20190076500A1 (en) * 2017-09-13 2019-03-14 Novartis Ag Combinations comprising fxr agonists

Also Published As

Publication number Publication date
IL273569B (en) 2021-12-01
BR112020005074A2 (pt) 2020-09-15
MX2020007273A (es) 2022-05-23
CA3076614A1 (en) 2019-04-04
SG11202002253SA (en) 2020-04-29
HUE057377T2 (hu) 2022-05-28
IL288340B1 (en) 2023-01-01
EP4523744A2 (en) 2025-03-19
EP3687523A1 (en) 2020-08-05
SI3687523T1 (sl) 2022-05-31
AU2018342323A1 (en) 2020-04-16
CY1124894T1 (el) 2023-01-05
ES2902349T3 (es) 2022-03-28
CA3076614C (en) 2023-02-07
EP3973959B8 (en) 2025-01-15
AU2021254641A1 (en) 2021-11-18
JP7023371B2 (ja) 2022-02-21
LT3687523T (lt) 2022-03-25
IL273569A (en) 2020-05-31
PL3687523T3 (pl) 2022-02-21
MX392537B (es) 2025-03-04
HRP20212010T1 (hr) 2022-04-01
US20210283078A1 (en) 2021-09-16
FI3973959T3 (fi) 2025-02-03
IL288340B2 (en) 2023-05-01
ZA202001646B (en) 2021-08-25
SI3973959T1 (sl) 2025-03-31
AU2018342323B2 (en) 2021-09-23
HUE070033T2 (hu) 2025-05-28
CN111132675A (zh) 2020-05-08
JP2020535225A (ja) 2020-12-03
SMT202200171T1 (it) 2022-05-12
LT3973959T (lt) 2025-01-10
PT3687523T (pt) 2021-12-06
ES3012120T3 (en) 2025-04-08
UA125600C2 (uk) 2022-04-27
CN111132675B (zh) 2023-04-25
NZ762976A (en) 2021-11-26
WO2019067373A1 (en) 2019-04-04
RU2020114644A (ru) 2021-10-27
AU2021254641B2 (en) 2022-02-24
KR102376794B1 (ko) 2022-03-18
RU2020114644A3 (enExample) 2022-02-14
DK3973959T3 (da) 2025-01-20
EP4523744A3 (en) 2025-06-04
PL3973959T3 (pl) 2025-03-24
US20190105291A1 (en) 2019-04-11
EP3973959B1 (en) 2024-12-11
PT3973959T (pt) 2025-01-24
EP3973959A1 (en) 2022-03-30
KR20200058458A (ko) 2020-05-27
RS62790B1 (sr) 2022-02-28
IL288340A (en) 2022-01-01
EP3687523B1 (en) 2021-11-03

Similar Documents

Publication Publication Date Title
HRP20250022T1 (hr) Liječenje kolestatskog pruritusa sa seladelparom
HRP20210819T1 (hr) Fenfluramin za uporabu u liječenju dravet sindroma
HRP20241461T1 (hr) Aprocitentan za uporabu u liječenju hipertenzije i povezanih bolesti u kombinaciji s valsartanom
JP2020535225A5 (enExample)
JP2018193377A5 (enExample)
HRP20230222T1 (hr) Modulatori prolijekova integriranog puta stresa
HRP20210529T1 (hr) Inhibitori za mk2 i njihove uporabe
AR129504A2 (es) Hidrato de diclorhidrato de omecamtiv mecarbil, formas cristalinas, y composiciones farmacéuticas
HRP20211314T1 (hr) 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu uporabu
JP2013018787A5 (enExample)
HRP20241734T1 (hr) Pripravak za uporabu u prevenciji ili suzbijanju miopije
HRP20192202T1 (hr) Acc inhibitori i njihove upotrebe
HRP20221158T1 (hr) Sredstva za izazivanje apoptoze
HRP20220759T1 (hr) Pripravci i postupci koji ih koriste za liječenje neurodegenerativne i mitohondrijske bolesti
HRP20180591T1 (hr) Inhibitori kinaze serina ili treonina
BR112017025673A2 (pt) stent de válvula atrioventricular com mecanismo de reter e apertar folheto nativo
JP2015147774A5 (enExample)
JP2014111603A5 (enExample)
HRP20220903T1 (hr) Seladelpar za liječenje primarnog bilijarnog kolangitisa
IL247227A0 (en) -2,4disubstituted phenylene-1,5-diamine derivatives and their uses, and pharmaceutical compounds and compounds obtained from them
HRP20171175T1 (hr) Novi triciklički spojevi
MX388210B (es) Esteroides neuroactivos y métodos para su uso.
IL292465B1 (en) Neuroactive compounds and methods of using them
HRP20240121T1 (hr) Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine
ES2948324R1 (es) Proceso para preparar (15alfa,16alfa,17beta)-estra-1,3,5(10)-trieno-3,15,16,17-tetrol monohidrato (Estetrol monohidrato)